XML 99 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment, Customer and Geographic Information
 12 Months Ended
Dec. 31, 2013
Segment, Customer and Geographic Information

Note 18. Segment, Customer and Geographic Information

The Company continues to operate in only one segment, blood safety. The Company’s chief executive officer is the chief operating decision maker who evaluates performance based on the net revenues and operating loss of the blood safety segment. The Company considers the sale of all of its INTERCEPT Blood System products to be similar in nature and function, and any revenue earned from services is minimal.

The Company’s operations outside of the United States include a wholly-owned subsidiary headquartered in Europe. The Company’s operations in the United States are responsible for the research and development and global commercialization of the INTERCEPT Blood System, while operations in Europe are responsible for the commercialization efforts of the platelet and plasma systems in Europe, The Commonwealth of Independent States and the Middle East. Product revenues are attributed to each region based on the location of the customer, and in the case of non-product revenues, on the location of the collaboration partner.

The Company had the following significant customers that accounted for more than 10% of the Company’s total product revenue, all of which operate in a country outside of the United States, during the years ended December 31, 2013, 2012 and 2011 (in percentages):

 

     Year Ended December 31,  
         2013             2012             2011      

Movaco, S.A.

      18 %      19 %      21 % 

Etablissement Francais du Sang

      17 %      20 %      24 % 

Delrus Inc.

      *        12 %      12 % 

 

* Represents an amount less than 10% of product revenue

The Company also recognized government grants and cooperative agreements revenue which represented less than 1% of total revenue and 7% of total revenue, during the years ended December 31, 2012 and 2011, respectively. The Company recognized no revenue from governmental grants and cooperative agreements during the year ended December 31, 2013.

Net revenues by geographical location was based on the location of the customer, in the case of product revenues, and in the location of the collaboration partner, in the case of non-product revenues, during the years ended December 31, 2013, 2012 and 2011 and was as follows (in thousands):

 

     Year Ended December 31,  
     2013      2012      2011  

Product Revenue:

         

France

    $ 7,030       $ 7,321       $ 7,385   

Spain and Portugal

      7,033         7,061         6,504   

CIS

      8,220         8,016         3,754   

Belgium

      3,971         4,016         3,703   

Switzerland

      4,078         3,866         3,315   

Other countries

      9,325         6,415         5,941   
  

 

 

     

 

 

     

 

 

  

Total product revenue

      39,657         36,695         30,602   

Government grants and cooperative agreements:

         

United States

      —         91         2,442   
  

 

 

     

 

 

     

 

 

  

Total government grants and cooperative agreements

      —         91         2,442   
  

 

 

     

 

 

     

 

 

  

Total revenue

    $ 39,657       $ 36,786       $ 33,044   
  

 

 

     

 

 

     

 

 

  

 

Long-lived assets by geographical location, which consist of property and equipment, net, intangible assets, net, and certain other assets, at December 31, 2013 and 2012 were as follows (in thousands):

 

     December 31,  
      2013      2012  

United States

    $ 3,088       $ 2,895   

Europe

      445         349   
  

 

 

     

 

 

  

Total long-lived assets

    $ 3,533       $ 3,244